Subscribe to RSS

DOI: 10.1055/s-0045-1809993
Insomnia Improved by Intravenous Mesenchymal Stem Cell Transplant: A Case Report
Authors
Funding Source This study received no funding.

Abstract
While several therapeutic options for insomnia are currently available, they often require long-term use and come with certain disadvantages. Given insomnia's significant impact on health overall, more effective treatments are warranted. Here, we report two patients with moderate to severe insomnia whose symptoms significantly improved following the intravenous administration of ex vivo-expanded bone marrow-derived mesenchymal stem cells (MSC).
The cases were 50-year-old and 38-year-old men with mild diabetes. They both developed insomnia several years ago and suffered from it despite taking some medications. We cultured their bone-marrow-derived MSCs and intravenously administered 1,5 × 108 cells to each patient. After the treatment, the insomnia of both patients was drastically improved, while diabetes itself showed only mild improvement. Notably, their improvements were associated with an increase in plasma interleukin-4 levels. This is the first case report demonstrating the therapeutic effects of MSCs on insomnia.
Ethical Declaration
This case study was conducted in accordance with the Helsinki Declaration. The ethics committee in Japan Tokyo Stem Cell Transplant Research Institute, consisting of experts in several areas including stem cell research, stem cell treatment, law in medicine and human rights, approved this stem cell treatment, and the approval number is A005.
Data Availability
The data of the clinical record of this patient are available from the author upon request.
Publication History
Received: 08 September 2024
Accepted: 19 May 2025
Article published online:
16 September 2025
© 2025. Brazilian Sleep Academy. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Revinter Publicações Ltda.
Rua Rego Freitas, 175, loja 1, República, São Paulo, SP, CEP 01220-010, Brazil
-
References
- 1 Diagnosis of insomnia ( https://www.nhlbi.nih.gov/health/insomnia/diagnosis ).
- 2 Bhaskar S, Hemavathy D, Prasad S. Prevalence of chronic insomnia in adult patients and its correlation with medical comorbidities. J Family Med Prim Care 2016; 5 (04) 780-784
- 3 Morin CM, Drake CL, Harvey AG. et al. Insomnia disorder. Nat Rev Dis Primers 2015; 1 (01) 15026
- 4 Borbély AA, Daan S, Wirz-Justice A, Deboer T. The two-process model of sleep regulation: a reappraisal. J Sleep Res 2016; 25 (02) 131-143
- 5 Besedovsky L, Lange T, Haack M. The Sleep-Immune Crosstalk in Health and Disease. Physiol Rev 2019; 99 (03) 1325-1380
- 6 Lo YJ, Mishra VK, Lo HY, Dubey NK, Lo WC. Clinical Spectrum and Trajectory of Innovative Therapeutic Interventions for Insomnia: A Perspective. Aging Dis 2023; 14 (04) 1038-1069
- 7 George S, Hamblin MR, Abrahamse H. Differentiation of Mesenchymal Stem Cells to Neuroglia: in the Context of Cell Signalling. Stem Cell Rev Rep 2019; 15 (06) 814-826
- 8 Kaminska A, Radoszkiewicz K, Rybkowska P, Wedzinska A, Sarnowska A. Interaction of Neural Stem Cells (NSCs) and Mesenchymal Stem Cells (MSCs) as a Promising Approach in Brain Study and Nerve Regeneration. Cells 2022; 11 (09) 1464
- 9 Liu Q, Luo X, Liang Z. et al. Coordination between circadian neural circuit and intracellular molecular clock ensures rhythmic activation of adult neural stem cells. Proc Natl Acad Sci U S A 2024; 121 (08) e2318030121
- 10 Song N, Scholtemeijer M, Shah K. Mesenchymal Stem Cell Immunomodulation: Mechanisms and Therapeutic Potential. Trends Pharmacol Sci 2020; 41 (09) 653-664
- 11 Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005; 105 (04) 1815-1822
- 12 Jin Q-H, Kim H-K, Na J-Y, Jin C, Seon J-K. Anti-inflammatory effects of mesenchymal stem cell-conditioned media inhibited macrophages activation in vitro. Sci Rep 2022; 12 (01) 4754
- 13 Honda Pazili T. A Severe Alzheimer's Disease Patient Improved by Intravenous Mesenchymal Stem Cell Transplant. Case Rep Neurol Med 2024; 2024: 8353492
- 14 Okajima I, Miyamoto T, Ubara A. et al. Evaluation of Severity Levels of the Athens Insomnia Scale Based on the Criterion of Insomnia Severity Index. Int J Environ Res Public Health 2020; 17 (23) 8789
- 15 Jim HSL, Evans B, Jeong JM. et al. Sleep disruption in hematopoietic cell transplantation recipients: prevalence, severity, and clinical management. Biol Blood Marrow Transplant 2014; 20 (10) 1465-1484
- 16 Boonstra L, Harden K, Jarvis S. et al. Sleep disturbance in hospitalized recipients of stem cell transplantation. Clin J Oncol Nurs 2011; 15 (03) 271-276
- 17 Khaeranih A, Basir H, Umbas DG, Bahar A, Kaelan C. Description of sleep disorders in radiotherapy patients of head and neck cancer. Medicina Clínica Práctica. 2021; 4: 100201
- 18 Murayama T, Ito Y, Narita K, Ishida T, Hinotsu S, Fujita M. The effect of lemborexant on insomnia in patients with psychiatric disorders: Detailed evaluation using the Athens Insomnia Scale. PCN Rep 2024; 3 (01) e165
- 19 Gärtner Y, Bitar L, Zipp F, Vogelaar CF. Interleukin-4 as a therapeutic target. Pharmacol Ther 2023; 242: 108348
- 20 Xia L, Zhang P, Niu JW. et al. Relationships Between a Range of Inflammatory Biomarkers and Subjective Sleep Quality in Chronic Insomnia Patients: A Clinical Study. Nat Sci Sleep 2021; 13: 1419-1428
- 21 Schulze M, Belema-Bedada F, Technau A, Braun T. Mesenchymal stem cells are recruited to striated muscle by NFAT/IL-4-mediated cell fusion. Genes Dev 2005; 19 (15) 1787-1798
- 22 Lin T, Kohno Y, Huang JF. et al. Preconditioned or IL4-Secreting Mesenchymal Stem Cells Enhanced Osteogenesis at Different Stages. Tissue Eng Part A 2019; 25 (15-16): 1096-1103
- 23 Ueno M, Lo CW, Barati D. et al. Interleukin-4 overexpressing mesenchymal stem cells within gelatin-based microribbon hydrogels enhance bone healing in a murine long bone critical-size defect model. J Biomed Mater Res A 2020; 108 (11) 2240-2250
- 24 Elkhenany H, AlOkda A, El-Badawy A, El-Badri N. Tissue regeneration: Impact of sleep on stem cell regenerative capacity. Life Sci 2018; 214: 51-61
- 25 Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 2011; 11 (02) 98-107
- 26 Kubota T, Inoue M, Kubota N. et al. Downregulation of macrophage Irs2 by hyperinsulinemia impairs IL-4-indeuced M2a-subtype macrophage activation in obesity. Nat Commun 2018; 9 (01) 4863